Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Reumatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 2
ClinicalTrials.gov
A Randomised, Double Blind, Placebo-controlled, Multiple Dose, Phase 2b, 24 Week Trial Followed by an Open Label Extension of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
INTERVENTIONAL
Inicio: 1 de ago de 2012
ID: NCT01636817
Reclutando
ClinicalTrials.gov
EEG Alpha Rhythm Modulation Using Sham Neurofeedback During Attentional Control in a Virtual Reality Environment
OBSERVATIONAL
Inicio: 1 de jul de 2025
ID: NCT06748976
Completado
Fase 3
ClinicalTrials.gov
A Multicentre, Randomised, Double-blind, Placebo-Controlled Phase 3 Extension Study to Characterise the Long-term Safety and Tolerability of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus.
INTERVENTIONAL
Inicio: 30 de jun de 2016
ID: NCT02794285
Completado
Fase 3
ClinicalTrials.gov
A Multicentre, 12 Week Double Blind Placebo Controlled Randomized Study Of Etanercept On A Background Nsaid In The Treatment Of Adult Subjects With Non Radiographic Axial Spondyloarthritis With A 92 Week Open Label Extension
INTERVENTIONAL
Inicio: 1 de feb de 2011
ID: NCT01258738
Completado
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects With Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 21 de sept de 2017
ID: NCT03252587
Desconocido
ClinicalTrials.gov
PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors
OBSERVATIONAL
Inicio: 1 de mar de 2021
ID: NCT04821206
Completado
Fase 2
ClinicalTrials.gov
A Phase II Open-Label Extension Study of Patients Previously Enrolled in Study GA29350 to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 30 de nov de 2016
ID: NCT02983227
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 15 de oct de 2015
ID: NCT02349061
Completado
Fase 1
ClinicalTrials.gov
A Phase 1b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI-545, a Fully Human Anti-Interferon-Alpha Monoclonal Antibody, in Patients With Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 1 de jun de 2007
ID: NCT00482989
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Moderate to Severe Active Systemic Lupus Erythematosus While on Background Standard of Care Therapy
INTERVENTIONAL
Inicio: 14 de mar de 2024
ID: NCT05835310
Completado
Fase 3
ClinicalTrials.gov
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
INTERVENTIONAL
Inicio: 2 de ago de 2016
ID: NCT02757352
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase III Trial to Evaluate Efficacy and Safety of Secukinumab Administered Subcutaneously Versus Placebo, in Combination With a Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)
INTERVENTIONAL
Inicio: 22 de mar de 2023
ID: NCT05767034
Completado
ClinicalTrials.gov
Long-term Safety Follow-up of REMICADE (RESULTS)
OBSERVATIONAL
Inicio: 1 de feb de 2002
ID: NCT00261976
Reclutando
Fase 2
ClinicalTrials.gov
An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 23 de may de 2023
ID: NCT05848258
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
INTERVENTIONAL
Inicio: 12 de abr de 2016
ID: NCT02696798
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (Sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T)
INTERVENTIONAL
Inicio: 7 de ago de 2013
ID: NCT01856309
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BMS-817399 in Adults With Active, Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01404585
Completado
Fase 3
ClinicalTrials.gov
Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in WA17822
INTERVENTIONAL
Inicio: 1 de ago de 2005
ID: NCT00721123
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Active-Controlled, Double-Blind Study Comparing Upadacitinib (ABT-494) to Abatacept in Subjects With Moderately to Severely Active Rheumatoid Arthritis With Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs) on Stable Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs (csDMARDs)
INTERVENTIONAL
Inicio: 9 de may de 2017
ID: NCT03086343
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Parallel Group Study of the Safety, Disease Remission and Prevention of Structural Joint Damage During Treatment With Tocilizumab (TCZ), as a Monotherapy and in Combination With Methotrexate (MTX), Versus Methotrexate in Patients With Early, Moderate to Severe Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 31 de oct de 2009
ID: NCT01007435
Anterior
1
...
20
21
22
...
434
Siguiente
Filtros